| 摘要 |
There is described a proliposome powder, said powder comprising discrete particles each comprising in a single phase (1) a biologically active component, (2) a stabilising proportion of tocopherol, and (3) a lipid or mixture of lipids having a phase transition temperature of below 37 DEG C. Also described is a process for the preparation of, and the pharmaceutical use of, the powder. |
